Camos Syndrome
Description
CAMOS syndrome is characterised by the association of a non-progressive congenital ataxia, severe intellectual deficit, optic atrophy and structural anomalies of the skin vessels. It has been described in five children from a large consanguineous Lebanese family. Short stature and microcephaly were also reported. Transmission is autosomal recessive.
Clinical Features
Top most frequent phenotypes and symptoms related to Camos Syndrome
- Intellectual disability
- Seizures
- Microcephaly
- Ataxia
- Muscular hypotonia
- Spasticity
- Motor delay
- Dysarthria
- Optic atrophy
- Renal insufficiency
And another 5 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Camos Syndrome Is also known as scar5, cerebellar ataxia-intellectual disability-optic atrophy-skin abnormalities syndrome.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Camos Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Ataxia Exome Panel.
By Genetic Services Laboratory University of Chicago (United States).
BCS1L, RTN2, SACS, SCN1A, SCN2A, SCN8A, SCO1, SDHA, SDHD, SLC16A2, SLC17A5, SLC19A2, SLC1A3, SLC20A2, SLC2A1, SLC6A1, SLC9A1, SLC9A6, SNAP25, SOD1 , (...)
View the complete list with 457 more genes
Specificity
1 %
Genes
100 % |
WDR73 mutation analysis (Galloway-Mowat syndrome).
By Laboratory of genome diagnostics Academic Medical Center, University of Amsterdam (Netherlands).
WDR73
Specificity
100 %
Genes
50 % |
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
SGPL1, SMARCAL1, TRPC6, WT1, NPHS2, ANLN, CD2AP, TP53RK, ACTN4, SCARB2, PLCE1, XPO5, OSGEP, NUP205, CRB2, MAGI2, COQ8B, KANK1, COQ6, COL4A3 , (...)
View the complete list with 29 more genes
Specificity
3 %
Genes
50 % |
Galloway-Mowat Syndrome via WDR73 Gene Sequencing with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
WDR73
Specificity
100 %
Genes
50 % |
Nephrotic syndrome and related disorders Comprehensive panel.
By Connective Tissue Gene Tests (United States).
SGPL1, SMARCAL1, TRPC6, WT1, NPHS2, ANLN, CD2AP, ACTN4, SCARB2, PLCE1, NUP205, CRB2, MAGI2, COQ8B, COQ6, COL4A3, COL4A4, COL4A5, COL4A6, PDSS2 , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
50 % |
Nephrotic syndrome and related disorders NGS panel.
By Connective Tissue Gene Tests (United States).
SGPL1, SMARCAL1, TRPC6, WT1, NPHS2, ANLN, CD2AP, ACTN4, SCARB2, PLCE1, NUP205, CRB2, MAGI2, COQ8B, COQ6, COL4A3, COL4A4, COL4A5, COL4A6, PDSS2 , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
50 % |
Nephrotic syndrome and related disorders Deletion / Duplication panel.
By Connective Tissue Gene Tests (United States).
SGPL1, SMARCAL1, TRPC6, WT1, NPHS2, ANLN, CD2AP, ACTN4, SCARB2, PLCE1, NUP205, CRB2, MAGI2, COQ8B, COQ6, COL4A3, COL4A4, COL4A5, COL4A6, PDSS2 , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
50 % |
Mental retardation - different panels.
By Institute of Human Genetics Uniklinik RWTH Aachen (Germany).
RGS7, RIT1, RMRP, BCS1L, RPL10, RPS6KA3, RRAS, SALL1, SC5D, ATXN10, BLM, SCN1A, SCN2A, SCN8A, SCO2, AIMP1, SDCCAG8, SDHA, SDHB, SGSH , (...)
View the complete list with 845 more genes
Specificity
1 %
Genes
50 % |
You can get up to 17 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42 OSSEOUS HETEROPLASIA, PROGRESSIVE; POH HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL CANDIDIASIS, FAMILIAL, 2; CANDF2 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 2; CAMRQ2